BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8880047)

  • 1. Variability in the rate of 6-mercaptopurine methylation in the erythrocytes, liver and kidney in an Italian population.
    Ferroni MA; Marchi G; Sansone E; Romeo P; Giulianotti PC; Pietrabissa A; Mosca F; Pacifici GM
    Eur J Clin Pharmacol; 1996; 51(1):23-9. PubMed ID: 8880047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults.
    McLeod HL; Krynetski EY; Wilimas JA; Evans WE
    Pharmacogenetics; 1995 Oct; 5(5):281-6. PubMed ID: 8563768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population.
    Kubota T; Nishida A; Takeuchi K; Iida T; Yokota H; Higashi K; Nakahara K; Hanai H; Iga T
    Ther Drug Monit; 2004 Jun; 26(3):319-21. PubMed ID: 15167635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.
    Weinshilboum RM; Sladek SL
    Am J Hum Genet; 1980 Sep; 32(5):651-62. PubMed ID: 7191632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.
    Szumlanski CL; Honchel R; Scott MC; Weinshilboum RM
    Pharmacogenetics; 1992 Aug; 2(4):148-59. PubMed ID: 1306116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population.
    Klemetsdal B; Straume B; Wist E; Aarbakke J
    Eur J Clin Pharmacol; 1993; 44(2):147-52. PubMed ID: 8453958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.
    Yates CR; Krynetski EY; Loennechen T; Fessing MY; Tai HL; Pui CH; Relling MV; Evans WE
    Ann Intern Med; 1997 Apr; 126(8):608-14. PubMed ID: 9103127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.
    Relling MV; Hancock ML; Rivera GK; Sandlund JT; Ribeiro RC; Krynetski EY; Pui CH; Evans WE
    J Natl Cancer Inst; 1999 Dec; 91(23):2001-8. PubMed ID: 10580024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity.
    Klemetsdal B; Straume B; Lysaa R; Giverhaug T; Aarbakke J
    Eur J Clin Pharmacol; 1995; 48(6):495-9. PubMed ID: 8582469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiopurine methyltransferase activity in American white subjects and black subjects.
    McLeod HL; Lin JS; Scott EP; Pui CH; Evans WE
    Clin Pharmacol Ther; 1994 Jan; 55(1):15-20. PubMed ID: 8299312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference in red blood cell thiopurine methyltransferase activity.
    Klemetsdal B; Wist E; Aarbakke J
    Scand J Clin Lab Invest; 1993 Nov; 53(7):747-9. PubMed ID: 8272762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia.
    McLeod HL; Relling MV; Liu Q; Pui CH; Evans WE
    Blood; 1995 Apr; 85(7):1897-902. PubMed ID: 7703493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors.
    Pazmiño PA; Sladek SL; Weinshilboum RM
    Clin Pharmacol Ther; 1980 Sep; 28(3):356-67. PubMed ID: 7408396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurine S-methyltransferase activity in Japanese subjects: metabolic activity of 6-mercaptopurine 6-methylation in different TPMT genotypes.
    Nishida A; Kubota T; Yamada Y; Higashi K; Kitamura K; Nakahara K; Iga T
    Clin Chim Acta; 2002 Sep; 323(1-2):147-50. PubMed ID: 12135816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity.
    Lennard L; Welch JC; Lilleyman JS
    Br J Clin Pharmacol; 1997 Nov; 44(5):455-61. PubMed ID: 9384462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a high-performance liquid chromatography method for thiopurine S-methyltransferase activity in whole blood using 6-mercaptopurine as substrate.
    Rieger H; Schmidt P; Schaeffeler E; Abe M; Schiffhauer M; Schwab M; von Ahsen N; Zurek G; Kirchherr H; Shipkova M; Wieland E
    Clin Chem Lab Med; 2018 Apr; 56(5):803-809. PubMed ID: 29194039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects.
    Rossi AM; Bianchi M; Guarnieri C; Barale R; Pacifici GM
    Eur J Clin Pharmacol; 2001 Apr; 57(1):51-4. PubMed ID: 11372592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.
    Lennard L; Lilleyman JS; Van Loon J; Weinshilboum RM
    Lancet; 1990 Jul; 336(8709):225-9. PubMed ID: 1973780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
    Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
    Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients.
    Mircheva J; Legendre C; Soria-Royer C; Thervet E; Beaune P; Kreis H
    Transplantation; 1995 Oct; 60(7):639-42. PubMed ID: 7570968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.